TP53 and breast cancer: Surprisingly, we found that in this system, BlgCre Brca1f/f p53+/− mice carrying two conditional knockout Lyn alleles had a shorter overall survival than that of BlgCre Brca1f/f p53+/− mice heterozygous or wild type for Lyn, but there was no difference in mammary tumour-specific survival.